Member Content
Unusual Calls Bought in Specialty Minerals Producer for Possible Buyout
Compass Minerals (CMP) unusual activity recently with 4/8 and 4/9 buyers of 12,250 December $15 calls, a $2M position now having gained nicely already from entry. CMP shares flipped to positive YTD last week and broke out of a multi-month downtrend and clearing a key...
Bullish Positioning in Small Cap Air Lessor
Air Lease (AL) is worth a closer look given recent options position with 1900 August $45 puts sold to open, 3000 August $50 calls bought and 2950 August $55 calls bought, positioning for upside over the next four months. AL shares are down 12% YTD but holding near the...
Call Buy Expects Rebound for Consulting Leader
FTI Consulting (FCN) unusual trade 3/27 as 1200 May $170 calls bought for $725,000 and continue to hold with the contracts up around 15%. FCN shares are -13.5% YTD with a 38.2% retracement of the big run from 2017 to 2024. FCN shares look to be basing and above $169.5...
FinTech Sees Bullish Options Positioning
Q2 (QTWO) back to interesting levels with the correction, testing its 200-week EMA a 50% retracement and staying above AVWAP from the 2023 low. QTWO has 1150 May $75 short puts in open interest from a 1/6 trade that are underwater but still plenty of potential to...
Near-Term Biotech Catalyst Watch in CG Oncology
CG Oncology (CGON) with an unusual bull trade on 4/15 as 2000 May $22.5 calls bought to open $2.15 to $2.65 sending IV higher and accounting for the only notable open interest in the name. CGON came public in 2024 and recently traded to a fresh low with shares -28%...
Put Sales Show Confidence in Small Biotech with T Cell Engagers
Culligan (CGEM) interesting action recently with 10,000 July $7.50 puts sold to open in a small Biotech trading $7.89, which tends to be a positive indication. CGEM shares are trading near record lows down 35% in 2025 though showing some bullish RSIU divergence into...
Small Biotech Attracts 10,000 Calls Bought for 2025 Catalysts
Arcus (RCUS) has recently seen 10,000 December $10 calls buy to open valued currently near $1.9M with shares down 47% YTD and the $835M Biotech trading 3.2X Sales and 0.85X Cash. RCUS is back to levels last seen in 2019 near an all-time low and short interest near 8%...
Put Sales See Floor in AI Imaging Play
Nano-X (NNOX) was a former bubble stock in 2021 that recently traded below $4 but saw some unusual options action as 4500 August $5 and 3000 November $5 short puts traded to open in late March implying a $4 floor for shares. NNOX has a $330M market cap and 12% of its...
Catalyst Watch: Option Players Position for Replimune Cancer Drug Approval
Replimune (REPL) options positioning recently caught my eye as 5500 May $5 puts sold to open on 4/9 and 5000 August $10 ITM puts sold to open on 4/1 $2.45 down to $2.30. On 4/2 the August $12.50 calls sold to open 12,000X in spreads with the $7.50 puts bought 12,000X,...
Small Cap Biotech Draws Massive Call Buy as Possible Takeout Bet
Biohaven (BHVN) is a small cap that saw a massive trade to close last week as 10,000 May $20 calls bought at $3 to $3.30 with shares -45% YTD but managed to close the week strong out of a base and above a rising 8-MA. BHVN is also a name that has seen size buys from...